There is a lack of data available concerning the baseline prevalence of meticillin resistant Staphylococcus aureus (MRSA) carriage among healthcare workers (HCWs) in the Republic of Ireland. This anonymous prevalence study screened HCWs for nasal carriage of MRSA in a non-acute healthcare facility (HCF) in Dublin and the prevalence rate among these HCWs was calculated. Three hundred and four HCWs were invited to participate, with 112 (37%) consenting to take part in the study. Nasal swabs were analysed by culture method for MRSA with reference to Health Protection Agency guidelines. Meticillin resistant isolates were examined for presence of MecA gene by real-time polymerase chain reaction. The overall rate of nasal carriage MRSA was found to be 8.9% (10/112), of whom eight were nurses, one was medical staff and one was household/catering staff. High-level mupirocin resistance was detected in two of the isolates. This study confirms a significant prevalence of MRSA carriage among the cohort studied, particularly among frontline HCWs. This emphasises the need for strict adherence to infection control protocols to minimise healthcare associated MRSA infections among patients in non-acute healthcare facilities. The detection of high level mupirocin resistant MRSA has implications for MRSA decontamination protocols.
AskarianMZeinalzadehAJaponiAAlborziAMemisuZA. (2009) Prevalence of nasal carriage of meticillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran. International Journal of Infectious Disease13: e241–e247. doi:10.1016/j.ijid.2008.11.02610.1016/j.ijid.2008.11.026.
2.
BaldwinNSGilpinDFHughesCMKearneyPMGardinerDACardwellCTunneyMM. (2009) Prevalence of meticillin-resistant Staphylococcus aureus colonization in residents and staff in nursing homes in Northern Ireland. Journal of American Geriatric Society57: 620–6.
3.
BisagaAPAQuetteKSabatiniLLovellEO. (2008) A prevalence study of meticillin-resistant S. aureus colonization in emergency department health care workers. Annals of Emergency Medicine52: 525–8.
4.
Clinical and Laboratory Standards Institute (CLSI) Document Number M2-A9. (2006) Performance standards for antimicrobial disk susceptibility tests; Approved Standards – Ninth Edition26(1): Jan 2006.
5.
Clinical and Laboratory Standards Institute (CLSI) Document Number M100-S18. (2008) Performance standards for antimicrobial susceptibility testing; Eighteenth Informational Supplement – 26(1): Jan 2008.
6.
CoatesTBaxRCoatesA. (2009) Nasal decolonisation of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. Journal of Antimicrobial Chemotherapy64: 9–15.
7.
CoiaJEDuckworthGJEdwardsDIFarringtonMFryCHumphreysHMallaghanCTuckerDR, for the Joint Working Party of the British Society of Antimicrobial Chemotherapy, the Hospital Infection Society, and the Infection Control Nurses Association. (2006) Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. Journal of Hospital Infection63S: S1–S44.
8.
CooksonBD. (1998) The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. Journal of Antimicrobial Chemotherapy41: 11–18.
9.
CosgroveSESakoulasGPerencevichENSchwaberMJKarchmerAWCarmeliY. (2003) Comparison of mortality associated with meticillin-resistant and meticillin susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clinical Infectious Diseases1: 53–9.
10.
CowanSTSteelKJ. (1993) Cowan and Steel’s manual for the identification of medical bacteria. 3rd edn In: BarrowGIFelthamRKA (eds.), Characteristics of Gram-Positive Bacteria, Chap. 6. Cambridge University Press: London, pp. 54–7.
11.
CrowcroftNSCatchpoleM. (2002) Mortality from meticillin-resistant Staphylococcus aureus in England and Wales: analysis of death certificates. British Medical Journal325: 1390–91.
12.
EmmersonAMEnstoneJEGriffinMKelseyMCSmythET. (1996) The Second National Prevalence Survey of infection in hospitals – overview of results. Journal of Hospital Infection; 3: 175–90.
FarzanaKRashidZAkhtarNSattarAAlikhanJNasirB. (2008) Nasal carriage of Staphylococci in health care workers: antimicrobial susceptibility profile. Pakistan Journal of Pharmaceutical Sciences21: 290–4. Available at: http://www.pjps.pk/CD-PJPS-21-3-08/Paper-15.pdf (accessed August 2009).
15.
GemmellCGEdwardsDIFraiseAPGouldKFRidgwayGLWavernRE. (2006) Guidelines for the prophylaxis and treatment of meticillin-resistant Staphylococcus aureus (MRSA) infections in the UK. Journal of Antimicrobial Chemotherapy57: 589–608.
16.
GrundmannHAires-de-SousaMBoyceJTiemersmaE. (2006) Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat. The Lancet368: 874–85.
17.
Health Protection Agency. (2007) Identification of Staphylococcus species, Micrococcus species and Rothia species. National Standard Method BSOP ID 7 Issue 2.1. Available at: http://www.hpa-standardmethods.org.uk/pdf_sops.asp. (accessed August 2009).
18.
Health Protection Agency. (2008) Investigation of specimens for screening for MRSA. National Standard Method BSOP 29 Issue 5.1. Available at: http://www.hpastandardmethods.org.uk/pdf_sops.asp. (accessed August 2009).
KlotzMOpperSHeegKZimmermannS. (2003) Detection of real-time fluorescence PCR assay. Journal of Clinical Microbiology41: 4683–7.
21.
MulqueenJCaffertyFCormicanMKeaneJDRossneyA. (2007) Nasal carriage of meticillin resistant staphylococcal aureus in GPs in the west of Ireland. British Journal of General Practioners57:811–13. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151814/pdf/bjpg57-811.pdf (accessed November 2008).
22.
SimorAEStuartTLLouieLWattCOfner-AgostiniMGravelDMulveyMLoebMMcGeerABryceEMatlowA, the Canadian Nosocomial Infection Surveillance Program. (2007) Mupirocin-resistant, meticillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals. Journal of Antimicrobial Agents and Chemotherapy51: 3880–6.
23.
SmythETMcIlvennyGEnstoneJEEmmersonAMHumphreysHFitzpatrickFDaviesENewcombeRGSpencerRC; on behalf of the Hospital Infection Society Prevalence Survey Steering Group. (2008) Four country healthcare associated infection prevalence survey 2006: overview and results. Journal of Hospital Infection3: 230–48.
